Informations:
Erreur:
ID
22969
Description
A Pharmacokinetic and Pharmacodynamic Study of MabThera (Rituximab) Plus Methotrexate in Patients With Rheumatoid Arthritis (RA); ODM derived from: https://clinicaltrials.gov/show/NCT00422942
Lien
https://clinicaltrials.gov/show/NCT00422942
Mots-clés
Versions (1)
- 19/06/2017 19/06/2017 -
Téléchargé le
19 juin 2017
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Eligibility Rheumatoid Arthritis NCT00422942
Eligibility Rheumatoid Arthritis NCT00422942
- StudyEvent: Eligibility
Similar models
Eligibility Rheumatoid Arthritis NCT00422942
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Adult | Age
Item
adult patients 18-80 years of age;
boolean
C0001675 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
C0001779 (UMLS CUI [2])
Rheumatoid Arthritis disease length
Item
ra for >=3 months;
boolean
C0003873 (UMLS CUI [1,1])
C0872146 (UMLS CUI [1,2])
C0872146 (UMLS CUI [1,2])
Outpatient procedure
Item
receiving outpatient treatment;
boolean
C1299353 (UMLS CUI [1])
Disease-Modifying Antirheumatic Drugs Quantity failed | Anti-TNF drug Absent | Biological treatment Absent
Item
failed treatment with >=1 dmard (but not anti tnf or other biologic therapy);
boolean
C0242708 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0231175 (UMLS CUI [1,3])
C1562242 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C1531518 (UMLS CUI [3,1])
C0332197 (UMLS CUI [3,2])
C1265611 (UMLS CUI [1,2])
C0231175 (UMLS CUI [1,3])
C1562242 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C1531518 (UMLS CUI [3,1])
C0332197 (UMLS CUI [3,2])
Methotrexate Dose Stable | Response Inadequate
Item
inadequate response to methotrexate, having taken and tolerated it for >=12 weeks, with a stable dose for >=4 weeks.
boolean
C0025677 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,3])
C1704632 (UMLS CUI [2,1])
C0205412 (UMLS CUI [2,2])
C0178602 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,3])
C1704632 (UMLS CUI [2,1])
C0205412 (UMLS CUI [2,2])
Autoimmune Disease Rheumatic | Rheumatoid Arthritis | Involvement Systemic Secondary to Rheumatoid Arthritis
Item
rheumatic autoimmune disease other than ra, or significant systemic involvement secondary to ra;
boolean
C0004364 (UMLS CUI [1,1])
C3495832 (UMLS CUI [1,2])
C0003873 (UMLS CUI [2])
C1314939 (UMLS CUI [3,1])
C0205373 (UMLS CUI [3,2])
C0175668 (UMLS CUI [3,3])
C0003873 (UMLS CUI [3,4])
C3495832 (UMLS CUI [1,2])
C0003873 (UMLS CUI [2])
C1314939 (UMLS CUI [3,1])
C0205373 (UMLS CUI [3,2])
C0175668 (UMLS CUI [3,3])
C0003873 (UMLS CUI [3,4])
Inflammatory joint disease | Rheumatoid Arthritis | Autoimmune disease (systemic)
Item
history of, or current, inflammatory joint disease other than ra, or other systemic autoimmune disorder;
boolean
C0683381 (UMLS CUI [1])
C0003873 (UMLS CUI [2])
C2895206 (UMLS CUI [3])
C0003873 (UMLS CUI [2])
C2895206 (UMLS CUI [3])
Rheumatoid Arthritis | Age
Item
diagnosis of ra before the age of 16;
boolean
C0003873 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
C0001779 (UMLS CUI [2])
Bone Operative Surgical Procedures | Operation on joint
Item
bone/joint surgery within 12 weeks of study;
boolean
C0262950 (UMLS CUI [1,1])
C0543467 (UMLS CUI [1,2])
C0185132 (UMLS CUI [2])
C0543467 (UMLS CUI [1,2])
C0185132 (UMLS CUI [2])
Anti-TNF drug | Biological treatment | natalizumab | blood cell depletion therapy
Item
prior use of anti-tnf or other biologic therapy, an anti-alpha 4 integrin, or any cell-depleting therapies.
boolean
C1562242 (UMLS CUI [1])
C1531518 (UMLS CUI [2])
C1172734 (UMLS CUI [3])
C0596186 (UMLS CUI [4])
C1531518 (UMLS CUI [2])
C1172734 (UMLS CUI [3])
C0596186 (UMLS CUI [4])